Option chain shows key data for MetaVia's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for MetaVia.

MetaVia (NASDAQ:MTVA) Stock, Option Chain

MetaVia

MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.

Stock market analysts

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ARQT

ARTV

MTVA

NUVL

This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

MetaVia Inc

Press Releases

MetaVia to Present at the Emerging Growth Conference in December

Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now

Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now

MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH

MetaVia to Participate in the 9th Annual MASH-TAG 2025 Conference After Releasing Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH

MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference

AEMD

ASPI

ATRA

BENF

BIXT

BNRG

BVAXF

CBIH

CSE:BIOV

ELRRF

ICON

JAGX

LGVN

LUCMF

NRXBF

NVAAF

OPWEF

PCYO

RERE

RGBP

SKYH

STXPF

TSX:ELO

TSX:VGZ

TSXV:IOT

TSXV:LUCA

TSXV:NRX

TSXV:OPW

TSXV:STU

TSXV:WRLG

TSXV:XBOT

UCAR

USEG

VIOT

WINT

WRLGF

XBOTF

ABVC BioPharma

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

Aprea Therapeutics

BioCardia

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Channel Therapeutics Corporation Common Stock

Channel Therapeutics

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Eterna Therapeutics

Evaxion Biotech A/S - American Depositary Share

Evaxion Biotech

HCW Biologics

HOOKIPA Pharma

Imunon

Kairos Pharma

MEI Pharma

Mainz Biomed

Minerva Neurosciences, Inc - Common Stock

Minerva Neurosciences

Ocean Biomedical

BiomX

PharmaCyte Biotech

SAB Biotherapeutics

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Senti Biosciences

Spruce Biosciences

Synlogic

HC Wainwright & Co.

Comments

MetaVia

MetaVia (MTVA) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga